85716-45-6

Upstream product

• 87326-88-3 methyl 6-deoxy-6-iodo-2,3-bis-O-(phenylmethyl)-α-D-glucopyranoside 
• 6217-21-6 methyl 2,3,4-tri-O-acetyl-6-desoxy-α-D-xylo-hex-5-enopyranoside 
• 6304-96-7 methyl 2,3,4-tri-O-acetyl-6-deoxy-6-iodo-α-D-glucopyranoside 
• 85716-43-4 methyl 6-deoxy-6-iodo-2,3,4-tri-O-benzyl-α-D-glucopyranoside 
• 53008-65-4 methyl 2,3,4-tri-O-benzyl-D-glucopyranoside 
• 7177-79-9 methyl 2,3-O-dibenzyl-4,6-O-benzylidene-α-D-glucopyranoside 
• 3162-96-7 4,6-O-benzylidene-1-O-methyl-α-D-glucopyranoside 
• 100-39-0 benzyl bromide 
• 4356-80-3 methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside 
• 73111-13-4 Methanesulfonic acid (2R,3R,4S,5R,6S)-3,4,5-tris-benzyloxy-6-methoxy-tetrahydro-pyran-2-ylmethyl ester 
• 13265-83-3 methyl 6-deoxy-α-D-xylo-hex-5-enopyranoside 
• 85716-44-5 methyl 2,3,4-tri-O-benzyl-α-d-xylo-hex-5-enopyranoside 

Downstream Products

• 110372-58-2 1D-(1,2,4,5C/3,5O)-1,7-Anhydro-2,3,4-tri-O-benzyl-5-C-(hydroxymethyl)-1,2,3,4,5-cyclohexanpentol 
• 121513-05-1 (2S)-(2,4,5/3)-2,3,4-tribenzyloxy-5-(tetrahydropyran-2-yloxy)cyclohexanone 
• 120090-15-5 (1S,2S,3S,4R)-2,3,4-Tris-benzyloxy-5-[1-methoxy-meth-(E)-ylidene]-cyclohexanol 
• 131289-29-7 (+)-(1R,2R,3S,4R,5S)-2,3,4-tribenzyloxy-5-(tert-butyldimethylsilyloxy)cyclohexanol 
• 671199-46-5 (4R,5S,6R)-4,5,6-tris(benzyloxy)cyclohex-2-en-1-one 
• 2037-48-1 2-deoxystreptamine 
• 121513-06-2 (1R,2R,3S,4S,5S)-2,3,4-Tris-benzyloxy-5-(tetrahydro-pyran-2-yloxy)-cyclohexanol 
• 118190-45-7 1L-(1,2,4,5/3)-2,3,4-tri-O-benzyl-1-O-p-toluenesulfonyl-1,2,3,4,5-cyclohexanepentol 
• 118190-49-1 (5R,5aR,9S)-9-((1R,2R,3S,4R,5S)-5-Amino-2,3,4-trihydroxy-cyclohexyloxy)-5-(4-hydroxy-3,5-dimethoxy-phenyl)-5,8,8a,9-tetrahydro-5aH-furo[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6-one 
• 118190-49-1 (5R,5aR,9S)-9-((1S,2R,3S,4R,5S)-5-Amino-2,3,4-trihydroxy-cyclohexyloxy)-5-(4-hydroxy-3,5-dimethoxy-phenyl)-5,8,8a,9-tetrahydro-5aH-furo[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6-one 
• 129193-14-2 (2S)-(2,4,5/3,6)-5-acetamido-2,3,4-tribenzyloxy-6-phenylsulphonylcyclohexanone ethylene acetal 
• 129193-12-0 (2S)-(2,4/3)-2,3,4-tribenzyloxy-6-phenylsulphonylcyclohex-5-enone ethylene acetal 
• 129193-13-1 (2S)-(2,4,5/3,6)-5-amino-2,3,4-tribenzyloxy-6-phenylsulphonylcyclohexanone ethylene acetal 
• 129193-10-8 (2S)-(2,4,5/3,6)-2,3,4-tribenzyloxy-5-chloro-6-phenylsulphonylcyclohexanone ethylene acetal 

Relevant academic research and scientific papers

Carbocyclic Substrate Analogues Reveal Kanosamine Biosynthesis Begins with the α-Anomer of Glucose 6-Phosphate

NtdC is an NAD-dependent dehydrogenase that catalyzes the conversion of glucose 6-phosphate (G6P) to 3-oxo-glucose 6-phosphate (3oG6P), the first step in kanosamine biosynthesis in Bacillus subtilis and other closely-related bacteria. The NtdC-catalyzed r

Transformation of glucose into a novel carbasugar amino acid dipeptide isostere

The synthesis of a novel carbasugar amino acid (15), starting from D-glucose and using the Ferrier rearrangement as a key step, is reported. Compound 15 is implemented as dipeptide isostere in the synthesis of a Leu-enkephalin analog. Copyright Taylor & F

Process for preparation of voglibose

A process capable of conveniently preparing voglibose at a low cost in a safe process, and an intermediate which can be suitably used in the process and a process for preparing the intermediate are provided. An inositol derivative represented by the formula (VI): wherein Prt is a protecting group of hydroxyl group; a process for preparing the inositol derivative, wherein a cyclohexanone compound represented by the formula (IV): wherein Prt is as defined above, is dihydroxyaminated using a dihydroxyaminating agent and a reducing agent; and a process for preparing voglibose represented by the formula (VIII): wherein the inositol derivative is oxidized to give an inositol compound, and the protecting group, Prt of the inositol compound is deprotected.

Surprising bacterial nucleotidyltransferase selectivity in the conversion of carbaglucose-1-phosphate

The drive to understand the molecular determinants of carbohydrate binding as well as the search for more chemically and biochemically stable sugar derivatives and carbohydrate-based therapeutics has led to the synthesis of a variety of analogues that rep

Palladium chloride mediated rearrangement of 6-deoxyhex-5-enopyranosides into cyclohexanones

PdCl2 was found to mediate the Ferrier rearrangement of broad range of substrates catalytically in neutral conditions. In this reaction, the stereoselectivity of newly formed chiral center was controlled by the hydroxyl protective groups on the starting sugar moiety and was rationally explained by the consideration of chair like conformations.

Enantioselective syntheses of polyhydroxylated nortropane derivatives: Total synthesis of (+) and (-)-calystegine B2

(+) and (-)-Calystegine B2 were prepared from D-Glucose via Ferrier reaction followed by regiospecific ring enlargement of a polysubstituted cyclohexanone and intramolecular cyclisation of 4-aminocycloheptanone.

SYNTHESIS OF AMYLOSTATIN (XG), α-GLUCOSIDASE INHIBITOR WITH BASIC PSEUDOTRISACCHARIDE STRUCTURE

The basic pseudotrisaccharide (1) constituting the common and essential building block of several α-glucosidase inhibitors of microbial origin was synthesized by coupling two synthons: the chiral cyclohexyl halide (11) and the 4'-amino-4'-deoxy-disaccharide (14).